Schechter Adam H
SEC CIK 1376841 · EDGAR
BoughtSold
Most active insiders at DVA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BERKSHIRE HATHAWAY INC | 10% | — | $273.73M |
| 2 | BUFFETT WARREN E | 10% | — | $199.95M |
| 3 | Rodriguez Javier | CEO, Dir | — | $14.53M |
| 4 | ACKERMAN JOEL | CFO, Treasuer | — | $9.89M |
| 5 | Maughan David Paul | COO, DKC | — | $4.09M |
| 6 | HEARTY JAMES O | CCO | — | $3.29M |
| 7 | Waters Kathleen Alyce | Chief Legal, Pub. Affairs Off | — | $3.21M |
| 8 | Pullin Dennis W | Dir | — | — |
| 9 | Moore Gregory J. | Dir | — | — |
| 10 | Hollar Jason M. | Dir | — | — |
| 13 | Schechter Adam H | Dir | — | — |
Transactions 61
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 18:10 | 2026-08-15 | DVA | DaVita | Schechter Adam H | Dir | A - Grant | $0.00 | +278 | 5,970 | +5% | $0 | |
| T | 2026-08-12 14:31 | 2026-08-11 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | S - Sale | $320.37 | -4,669 | 102.6K | -4% | -$1.50M |
| 2026-05-18 16:11 | 2026-05-15 | DVA | DaVita | Schechter Adam H | Dir | A - Grant | $0.00 | +250 | 5,692 | +5% | $0 | |
| T | 2026-05-13 09:30 | 2026-05-11 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | S - Sale | $254.50 | -5,903 | 107.2K | -5% | -$1.50M |
| 2026-03-30 | 2026-03-26 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | F - Tax | $268.38 | -26.1K | 113.1K | -19% | -$7.01M | |
| 2026-03-30 | 2026-03-26 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | A - Grant | $0.00 | +58.5K | 139.2K | +72% | $0 | |
| 2026-03-17 | 2026-03-15 | DVA | DaVita | Schechter Adam H | Dir | A - Grant | $0.00 | +332 | 5,442 | +6% | $0 | |
| 2026-03-05 | 2026-03-03 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | S - Sale | $279.96 | -8,705 | 80.8K | -10% | -$2.44M | |
| D | 2026-02-13 | 2026-02-11 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | M - OptEx | — | +3,656 | 91.0K | +4% | — |
| D | 2026-02-13 | 2026-02-11 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | F - Tax | $289.89 | -1,521 | 89.5K | -2% | -$440.9K |
| D | 2026-02-13 | 2026-02-11 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | S - Sale+OE | $284.38 | -5,273 | 87.3K | -6% | -$1.50M |
| DM | 2026-02-10 | 2026-02-06+ | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | F - Tax | $275.58 | -2,667 | 92.6K | -3% | -$735.0K |
| DM | 2026-02-10 | 2026-02-06+ | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | M - OptEx | — | +7,709 | 94.0K | +9% | — |
| 2025-11-17 | 2025-11-15 | DVA | DaVita | Schechter Adam H | Dir | A - Grant | $0.00 | +411 | 5,110 | +9% | $0 | |
| 2025-11-13 | 2025-11-11 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | S - Sale | $262.75 | -5,745 | 87.6K | -6% | -$1.51M | |
| 2025-08-19 | 2025-08-15 | DVA | DaVita | Schechter Adam H | Dir | A - Grant | $0.00 | +369 | 4,699 | +9% | $0 | |
| 2025-08-13 | 2025-08-11 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | S - Sale | $266.78 | -5,643 | 93.3K | -6% | -$1.51M | |
| 2025-05-16 | 2025-05-15 | DVA | DaVita | Schechter Adam H | Dir | A - Grant | $0.00 | +348 | 4,330 | +9% | $0 | |
| 2025-05-13 | 2025-05-12 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | S - Sale | $248.73 | -6,105 | 99.0K | -6% | -$1.52M | |
| 2025-03-31 | 2025-03-27 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | A - Grant | $0.00 | +30.5K | 118.7K | +35% | $0 | |
| 2025-03-31 | 2025-03-27 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | F - Tax | $231.67 | -13.6K | 105.1K | -11% | -$3.15M | |
| 2025-03-18 | 2025-03-15 | DVA | DaVita | Schechter Adam H | Dir | A - Grant | $0.00 | +349 | 3,982 | +10% | $0 | |
| D | 2025-02-13 | 2025-02-11 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | S - Sale+OE | $244.62 | -6,121 | 86.4K | -7% | -$1.50M |
| D | 2025-02-13 | 2025-02-11 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | M - OptEx | — | +2,963 | 89.4K | +3% | — |
| D | 2025-02-13 | 2025-02-11 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | F - Tax | $245.14 | -1,226 | 88.2K | -1% | -$300.5K |
| DM | 2025-02-10 | 2025-02-06+ | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | M - OptEx | — | +7,710 | 91.9K | +9% | — |
| DM | 2025-02-10 | 2025-02-06+ | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | F - Tax | $246.98 | -2,585 | 90.7K | -3% | -$638.4K |
| 2024-11-19 | 2024-11-15 | DVA | DaVita | Schechter Adam H | Dir | A - Grant | $0.00 | +312 | 3,633 | +9% | $0 | |
| 2024-11-13 | 2024-11-11 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | S - Sale | $243.47 | -6,189 | 87.4K | -7% | -$1.51M | |
| 2024-08-19 | 2024-08-15 | DVA | DaVita | Schechter Adam H | Dir | A - Grant | $0.00 | +333 | 3,321 | +11% | $0 | |
| 2024-05-17 | 2024-05-15 | DVA | DaVita | Schechter Adam H | Dir | A - Grant | $0.00 | +363 | 2,988 | +14% | $0 | |
| D | 2024-03-29 | 2024-03-27 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | M - OptEx | — | +72.4K | 125.4K | +137% | — |
| D | 2024-03-29 | 2024-03-27 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | F - Tax | $216.57 | -31.8K | 93.6K | -25% | -$6.89M |
| 2024-03-19 | 2024-03-15 | DVA | DaVita | Schechter Adam H | Dir | A - Grant | $0.00 | +366 | 2,625 | +16% | $0 | |
| D | 2024-02-13 | 2024-02-12 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | F - Tax | $227.45 | -1,231 | 53.0K | -2% | -$280.0K |
| D | 2024-02-13 | 2024-02-11 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | M - OptEx | — | +2,964 | 54.2K | +6% | — |
| D | 2024-02-08 | 2024-02-07 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | F - Tax | $223.71 | -1,149 | 51.3K | -2% | -$257.0K |
| D | 2024-02-08 | 2024-02-07 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | M - OptEx | — | +3,250 | 52.4K | +7% | — |
| D | 2024-02-06 | 2024-02-02 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | F - Tax | $221.54 | -822 | 49.2K | -2% | -$182.1K |
| D | 2024-02-06 | 2024-02-02 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | M - OptEx | — | +3,094 | 50.0K | +7% | — |
| 2023-11-17 | 2023-11-15 | DVA | DaVita | Schechter Adam H | Dir | A - Grant | $0.00 | +529 | 2,259 | +31% | $0 | |
| 2023-08-17 | 2023-08-15 | DVA | DaVita | Schechter Adam H | Dir | A - Grant | $0.00 | +475 | 1,730 | +38% | $0 | |
| 2023-05-17 | 2023-05-15 | DVA | DaVita | Schechter Adam H | Dir | A - Grant | $0.00 | +516 | 1,255 | +70% | $0 | |
| 2023-04-03 | 2023-03-30 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | A - Grant | $0.00 | +42.4K | 65.5K | +183% | $0 | |
| 2023-04-03 | 2023-03-30 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | F - Tax | $224.70 | -18.6K | 46.9K | -28% | -$4.19M | |
| 2023-03-17 | 2023-03-15 | DVA | DaVita | Schechter Adam H | Dir | A - Grant | $0.00 | +658 | 739 | +812% | $0 | |
| D | 2023-02-14 | 2023-02-11 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | M - OptEx | — | +2,656 | 24.4K | +12% | — |
| D | 2023-02-14 | 2023-02-13 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | F - Tax | $248.13 | -1,170 | 23.2K | -5% | -$290.3K |
| D | 2023-02-07 | 2023-02-06 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | F - Tax | $244.50 | -1,368 | 21.7K | -6% | -$334.5K |
| D | 2023-02-07 | 2023-02-04 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | M - OptEx | — | +3,507 | 23.1K | +18% | — |
| D | 2023-02-06 | 2023-02-02 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | F - Tax | $254.99 | -805 | 19.6K | -4% | -$205.3K |
| D | 2023-02-06 | 2023-02-02 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | M - OptEx | — | +2,773 | 20.4K | +16% | — |
| 2022-11-16 | 2022-11-15 | DVA | DaVita | Schechter Adam H | Dir | A - Grant | $0.00 | +81 | 81 | New | $0 | |
| D | 2022-11-03 | 2022-11-01 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | M - OptEx | — | +2,007 | 18.5K | +12% | — |
| D | 2022-11-03 | 2022-11-01 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | F - Tax | $222.56 | -893 | 17.6K | -5% | -$198.7K |
| D | 2022-02-08 | 2022-02-04 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | M - OptEx | — | +3,507 | 17.9K | +24% | — |
| D | 2022-02-08 | 2022-02-04 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | F - Tax | $277.48 | -1,412 | 16.5K | -8% | -$391.8K |
| D | 2022-02-04 | 2022-02-02 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | M - OptEx | — | +2,773 | 15.2K | +22% | — |
| D | 2022-02-04 | 2022-02-02 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | F - Tax | $273.18 | -803 | 14.4K | -5% | -$219.4K |
| D | 2021-11-03 | 2021-11-01 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | M - OptEx | — | +2,007 | 13.3K | +18% | — |
| D | 2021-11-03 | 2021-11-01 | LH | Labcorp | Schechter Adam H | Pres, CEO, Dir | F - Tax | $288.78 | -886 | 12.4K | -7% | -$255.9K |
Purchase Sale Sale after option exercise All abbreviations